Genmab A/S
CSE:GMAB
Genmab A/S
CSE:GMAB
Price:
2 019
DKK
0.6%
Market Closed
Market Cap:
kr129.5B
Relative Value
The Relative Value of one
GMAB
stock under the Base Case scenario is
hidden
DKK.
Compared to the current market price of 2 019 DKK,
Genmab A/S
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GMAB Relative Value
HIDDEN
Multiples Across Competitors
GMAB Competitors Multiples
Genmab A/S Competitors
Genmab A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Genmab A/S
CSE:GMAB
|
124.3B DKK | 34.6 | 83.7 | 87.3 | 91.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
386.2B USD | 6.5 | 164.5 | 16 | 22.7 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.7B USD | 5.5 | 28.1 | 19.9 | 19.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.2B USD | 6.4 | 22.8 | 15.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.4B USD | 9.9 | 31.7 | 23.2 | 24.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.9B USD | 5.6 | 18 | 15.2 | 17.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
87.7B AUD | 3.9 | 20.1 | 13.5 | 16.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 14.5 | 34 | 58.1 | 59.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
